{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:04:35Z","timestamp":1777485875373,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10637-017-0511-7","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T02:29:57Z","timestamp":1506047397000},"page":"813-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Metformin as a repurposed therapy in advanced non-small cell lung cancer (NSCLC): results of a phase II trial"],"prefix":"10.1007","volume":"35","author":[{"given":"Anish B.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kozuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Rohs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin P.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"511_CR1","unstructured":"Joshua AM, Zanella V, Bowes B et al (2012) A phase II study of neoadjuvant metformin in prostate carcinoma. AACR Annual meeting 2012, Clinical trials symposium, Chicago"},{"issue":"20","key":"511_CR2","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","volume":"27","author":"S Jiralerspong","year":"2009","unstructured":"Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27(20):3297\u20133302","journal-title":"J Clin Oncol"},{"issue":"3","key":"511_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cncr.27706","volume":"119","author":"S Kumar","year":"2013","unstructured":"Kumar S, Meuter A, Thapa P et al (2013) Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer 119(3):555\u2013562","journal-title":"Cancer"},{"issue":"1","key":"511_CR4","first-page":"8","volume":"28","author":"H Ashinuma","year":"2012","unstructured":"Ashinuma H, Takiguchi Y, Kitazono S et al (2012) Antiproliferative action of metformin in human lung cancer cell lines. Oncol Rep 28(1):8\u201314","journal-title":"Oncol Rep"},{"issue":"9","key":"511_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","volume":"3","author":"RM Memmott","year":"2010","unstructured":"Memmott RM, Mercado JR, Maier CR et al (2010) Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Phila) 3(9):1066\u20131076","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7503","key":"511_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, Donnelly LA, Emslie-Smith AM et al (2005) Metformin and reduced risk of cancer in diabetic patients. BMJ 330(7503):1304\u20131305","journal-title":"BMJ"},{"issue":"8","key":"511_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2337\/dc06-0997","volume":"29","author":"SL Bowker","year":"2006","unstructured":"Bowker SL, Majumdar SR, Veugelers P et al (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider. Diabetes Care 29(8):1990\u20131991","journal-title":"Diabetes Care"},{"issue":"9","key":"511_CR8","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.2337\/dc08-2175","volume":"32","author":"G Libby","year":"2009","unstructured":"Libby G, Donnelly LA, Donnan PT et al (2009) New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care 32(9):1620\u20131625","journal-title":"Diabetes Care"},{"issue":"4","key":"511_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1164\/rccm.201407-1395OC","volume":"191","author":"JJ Lin","year":"2015","unstructured":"Lin JJ, Gallagher EJ, Sigel K et al (2015) Survival of patients with stage IV lung cancer with diabetes treated with metformin. Am J Resp Crit Care Med 191(4):448\u2013454","journal-title":"Am J Resp Crit Care Med"},{"issue":"4","key":"511_CR10","doi-asserted-by":"publisher","first-page":"882A","DOI":"10.1378\/chest.10380","volume":"138","author":"PJ Mazzone","year":"2010","unstructured":"Mazzone PJ, Rai HS, Beukemann M et al (2010) The effect of metformin and thiazolidinedione use on lung cancer. Chest 138(4):882A","journal-title":"Chest"},{"issue":"22","key":"511_CR11","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1002\/cncr.26151","volume":"117","author":"BX Tan","year":"2011","unstructured":"Tan BX, Yao WX, Ge J et al (2011) Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer 117(22):5103\u20135111","journal-title":"Cancer"},{"issue":"23","key":"511_CR12","doi-asserted-by":"publisher","first-page":"35437","DOI":"10.18632\/oncotarget.8881","volume":"7","author":"G Wan","year":"2016","unstructured":"Wan G, Yu X, Chen P et al (2016) Metformin therapy associated with survival benefit in lung cancer patients with diabetes. Oncotarget 7(23):35437\u201335445","journal-title":"Oncotarget"},{"issue":"1","key":"511_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pharmthera.2011.09.004","volume":"133","author":"A Aljada","year":"2012","unstructured":"Aljada A, Mousa SA (2012) Metformin and neoplasia: implications and indications. Pharmacol Ther 133(1):108\u2013115","journal-title":"Pharmacol Ther"},{"issue":"1","key":"511_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1074\/jbc.275.1.223","volume":"275","author":"MY El-Mir","year":"2000","unstructured":"El-Mir MY, Nogueira V, Fontaine E et al (2000) Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem 275(1):223\u2013228","journal-title":"J Biol Chem"},{"issue":"10","key":"511_CR15","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1073\/pnas.0308061100","volume":"101","author":"RJ Shaw","year":"2004","unstructured":"Shaw RJ, Kosmatka M, Bardeesy N et al (2004) The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101(10):3329\u20133335","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"511_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","volume":"23","author":"DB Shackelford","year":"2013","unstructured":"Shackelford DB, Abt E, Gerken L et al (2013) LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell 23(2):143\u2013158","journal-title":"Cancer Cell"},{"issue":"7216","key":"511_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature07423","volume":"455","author":"L Ding","year":"2008","unstructured":"Ding L, Getz G, Wheeler DA et al (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455(7216):1069\u20131075","journal-title":"Nature"},{"issue":"7155","key":"511_CR18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06030","volume":"448","author":"H Ji","year":"2007","unstructured":"Ji H, Ramsey MR, Hayes DN et al (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448(7155):807\u2013810","journal-title":"Nature"},{"issue":"40","key":"511_CR19","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.1038\/sj.onc.1210418","volume":"26","author":"S Matsumoto","year":"2007","unstructured":"Matsumoto S, Iwakawa R, Takahashi K et al (2007) Prevalence and specificity of LKB1 genetic alterations in lung cancers. Oncogene 26(40):5911\u20135918","journal-title":"Oncogene"},{"issue":"57","key":"511_CR20","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1038\/sj.onc.1210594","volume":"26","author":"M Sanchez-Cespedes","year":"2007","unstructured":"Sanchez-Cespedes M (2007) A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 26(57):7825\u20137832","journal-title":"Oncogene"},{"issue":"7171","key":"511_CR21","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nature06358","volume":"450","author":"BA Weir","year":"2007","unstructured":"Weir BA, Woo MS, Getz G et al (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450(7171):893\u2013898","journal-title":"Nature"},{"issue":"21","key":"511_CR22","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J et al (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-na\u00efve patients with advanced-stage non-small cell lung cancer. J Clin Oncol 26(21):3543\u20133551","journal-title":"J Clin Oncol"},{"issue":"21","key":"511_CR23","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","volume":"20","author":"GV Scagliotti","year":"2002","unstructured":"Scagliotti GV, De Marinis F, Rinaldi M et al (2002) Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer. J Clin Oncol 20(21):4285\u20134291","journal-title":"J Clin Oncol"},{"issue":"2","key":"511_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP et al (2002) Comparison of four chemotherapy regimens for advanced non-small cell lung cancer. N Engl J Med 346(2):92\u201398","journal-title":"N Engl J Med"},{"issue":"23","key":"511_CR25","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1200\/JCO.2012.47.1102","volume":"31","author":"LG Paz-Ares","year":"2013","unstructured":"Paz-Ares LG, De Marinis F, Dediu M et al (2013) PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer. J Clin Oncol 31(23):2895\u20132902","journal-title":"J Clin Oncol"},{"issue":"4","key":"511_CR26","doi-asserted-by":"publisher","first-page":"pii:e002560","DOI":"10.1136\/bmjopen-2013-002560","volume":"3","author":"C Boch","year":"2013","unstructured":"Boch C, Kollmeier J, Roth A et al (2013) The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study. BMJ Open 3(4):pii:e002560","journal-title":"BMJ Open"},{"issue":"1","key":"511_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2015.08.024","volume":"369","author":"H Chen","year":"2015","unstructured":"Chen H, Yao W, Chu Q et al (2015) Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes. Cancer Lett 369(1):97\u2013102","journal-title":"Cancer Lett"},{"key":"511_CR28","unstructured":"ClinicalTrials.gov [Internet] (2017) Bethesda (MD): National Library of Medicine (US). Identifier NCT03048500, Parallel prrof of concept phase 2 study of Nivolumab and Metformin combination treatment in advanced non-small cell lung cancer with and without prior treatment with PD-1\/PD-L1 inhibitors. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03048500"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-017-0511-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-017-0511-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T05:11:35Z","timestamp":1678511495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-017-0511-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["511"],"URL":"https:\/\/doi.org\/10.1007\/s10637-017-0511-7","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"assertion":[{"value":"2 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research Involving Human Participants and\/or Animals- All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}